WO2003102123A2 - Kultursysteme zur sterilen kontinuierlichen kultivierung von zellen - Google Patents
Kultursysteme zur sterilen kontinuierlichen kultivierung von zellen Download PDFInfo
- Publication number
- WO2003102123A2 WO2003102123A2 PCT/DE2003/001826 DE0301826W WO03102123A2 WO 2003102123 A2 WO2003102123 A2 WO 2003102123A2 DE 0301826 W DE0301826 W DE 0301826W WO 03102123 A2 WO03102123 A2 WO 03102123A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cells
- gels
- cultivation
- culture
- poly
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0062—General methods for three-dimensional culture
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/30—Synthetic polymers
- C12N2533/40—Polyhydroxyacids, e.g. polymers of glycolic or lactic acid (PGA, PLA, PLGA); Bioresorbable polymers
Definitions
- the invention relates to culture systems and methods for the sterile continuous cultivation of cells in high densities and for reducing the seeding density at the beginning of the cultivation of cells in bioreactors.
- biodegradable gels that release low molecular weight components as nutrients for cell culture or 0 semisolid media that are diluted during the course of the culture and thereby release the culture space for colonization with cells in high density
- Polypeptide (block) copolymers partially consisting of poly (L-glutamine), are used as biodegradable gels, and methyl celluloses, alginates and agaroses 5 are used as semisolid media.
- the object of the invention is to enable new solutions for the cultivation of cells of high cell density and to reduce the minimum starting cell density (seeding density).
- the object was achieved by the development of culture systems and methods for the sterile continuous cultivation of cells in high densities, in which the cells are separated from the supply medium by embedding the cells in a gel and / or semisolide medium, which a support material is held.
- the solution according to the invention surprisingly makes it possible to start the cultivation of cells with very low seeding densities of ⁇ 10,000 cells per milliliter.
- the culture systems according to the invention contain, as gels, crosslinked polypeptides with a high glutamine content and / or as semisolid media, viscous liquids, in particular methyl celluloses, or liquids from microscopic gel pieces produced according to the invention.
- the semisolid medium used according to the invention is biodegradable or is diluted in the course of the culture and, as a result, the culture space can be used to the maximum by the cells in high density.
- Another advantage of the gels or semisolid matrices used according to the invention is that the low-molecular components released by biodegradation can serve as nutrients for cell culture.
- the term cells denotes natural and randomly or by manipulation degenerated cells of any species, and cells in high densities are understood here to mean concentrations of single cells in sterile culture of over 10 million cells per milliliter.
- the culture systems according to the invention contain a culture room with a plurality of fixed chambers and a supply room with a device for generating a variably adjustable gel / cell culture media mixture, the culture room and the supply room being semi-permeable from one another.
- the products obtained with the aid of the solution according to the invention - are cell components, viruses and active substances produced in and by cells - are free of compounds which are not typical of the media.
- Another surprising advantage of the solution according to the invention is that high cell densities are obtained in one and the same culture area and there is thus no need to switch to larger culture areas in the cultivation phase.
- Gels are crosslinked polypeptides with a high glutamine content or crosslinked alginates;
- Semisolid media are viscous liquids with a viscosity that is at least 20-100 times higher than that of water or even higher, e.g. Solutions made from methyl cellulose (MC) or agar (note: not agarose, see http://www.mgm.musin.de/ête/elba/algen/algenl3.htm) as well as liquids consisting of microscopic gel pieces.
- a medium is referred to as a gel, semisolid medium or growth-promoting semisolide medium in which individual cells can be deposited and propagated.
- Such gels are preferably cross-linked polypeptides with a high proportion of glutamine or cross-linked alginates, whereas semi-insulating media consist of viscous liquids, preferably methyl celluloses, or liquids consist of microscopic pieces of gel.
- the semisolid media optionally contain support materials.
- a support material eg a hollow fiber membrane
- Suitable materials are flat membranes, tubular membranes and woven networks.
- the membranes consist of polymers, for example polysulfones, polyether sulfones or polycarbonates, and also of polyesters from the group of polyalkylene terephthalates, in particular polyethylene terephthalate.
- Tubular membranes are hollow fiber membranes which e.g. can be produced by spinning processes or extrusion processes or which consist of flat membranes wound and welded into a tube.
- Woven nets are nonwovens in any geometry. Tubular membranes and nonwovens can be made of the same materials as the flat membranes. Filling the cell culture room in a bioreactor with a gel or a semisolid matrix leads to a higher viscosity in the cell culture room. If this cell culture area is inoculated with cells, then they are "fixed" in the matrix. The matrix reduces the rate of mass transfer around the cells, so that a micro-environment can arise. With an optimal matrix, each cell can build up its own micro-milieu, so that the cultivation of a single cell is possible.
- proteolytically degradable gels such as polypeptide (block) copolymers (AP Nowak, V. Breedveld, L. Pakstis, B. Ozbas, DJ Pine, D. Pochan and TJ Deming, Rapidly recovering hydrogel scaffolds from self-assembling diblock copolypeptides amphiphiles, Nature 417 (2002), pp. 424-428), the proteolytic degradation with the concentration of cell-specific proteases, ie with the cell number, positively correlated. If these polypeptide (block) copolymers are predominantly made up of poly (L-glutamine), the amino acid L-glutamine is formed during biodegradation, which in addition to glucose serves as the main nutrient source in animal cells.
- polypeptide (block) copolymers AP Nowak, V. Breedveld, L. Pakstis, B. Ozbas, DJ Pine, D. Pochan and TJ Deming, Rapidly recovering hydrogel scaffolds from self-assembling diblock copolypeptides amphiphiles
- a novel polypeptide (block) copolymer according to the invention is obtained by reacting poly (L-glutamic acid) in oxalyl chloride and introducing ammonia (Example 2.3.). It consists of poly (L-glutamine) and poly (L-glutamic acid), for example 89 mol% of poly (L-glutamine) and 11 mol% of poly (L-glutamic acid).
- methyl celluloses can also be used, the usability of which has been checked in cell culture. Methyl celluloses are currently mainly used in cell culture in cloning; they are commercial for this application and therefore readily available
- the new semisolid media according to the invention include gels which are obtained from human serum albumin (HSA) and glutardialdehyde by crosslinking.
- HSA human serum albumin
- glutardialdehyde by crosslinking.
- water is added to the solidified gels and comminuted using a dispersing device (Example 3). After processing, gel pieces result which have a size between 10 ⁇ m and 100 ⁇ m.
- 5 cells (mammalian cells) are cultivated.
- the features of the invention emerge from the elements of the claims and from the description, both individual features and several in the form of combinations representing advantageous designs for which protection is provided with this document is requested.
- the essence of the invention consists of a combination of known (general components of bioreactors) and new elements (semisolide media, held by supporting materials), which mutually influence one another and, in their new overall effect, result in a use advantage and the desired success, which lies in the fact that For the first time, a possibility to significantly reduce the minimum starting cell density (inoculation density) when culturing cells in high density is opened.
- the use of the culture systems and / or the methods according to the invention lies in the cultivation of cells of high density and in the reduction of the starting cell density at the beginning of the cultivation in bioreactors. It also lies in the production of cell products, cell components, viruses or active substances as well as in the production of pharmaceuticals and in the production of diagnostics. It also lies in the fact that gels and / or semisolide matrices are used to build up a micromilieu around the individual cell and thus as a prerequisite for lowering the inoculation density, they are diluted during the course of the culture and thereby the culture space for colonization with cells in high density release. It is also because they release small molecules as nutrients for cell culture.
- Cages are made from a penneable membrane and a plastic housing.
- the permeable membrane is a flacli membrane made of polyethylene terephthalate with uniform pores - with a pore diameter of 0.4 ⁇ m.
- Plastic housing is made of polycarbonate.
- the cages each contain an ImL culture room. They are kept submerged in a nutrient-containing solution so that the cells can be supplied via the membrane.
- the cages are infested with a 2% methyl cellulose / medium mixture (MC) and inoculated with cells.
- the inoculation concentrations are 5 x 10 3 , 5 x 10 4 , 5 x 10 5 and 5 x 10 6 cells / mL (Z / mL). These concentrations are given in Table 1 as day 0 cell concentrations.
- FIG. 1 Cell counts and vitalities
- Cells (1) are separated from the supplying medium (4), characterized in that they contain a gel (2) or a semisolide medium which is held by a support material (3).
- polypeptide (block) copolymers are prepared as follows: 2.1 .: Preparation of a monomer
- the N-carboxylic anhydride of glutamic acid is formed.
- the solvent is removed completely.
- the purification is carried out by recrystallization from ethyl acetate. Two bands are found in the Fourier-transformed IR spectrum at 1750 and 1815 cm “1 , which are typical for the cyclic anhydride formed.
- oxalyl chloride 1.0 g of poly (L-glutamic acid) is added.
- Oxalyl chloride is also a solvent.
- the polymer dissolves due to the reaction to the acid chloride. After 48 hours at room temperature, the solvent is stripped off and the remaining polymer is dissolved in 50 ml of THF.
- Gaseous ammonia is passed into the polymer solution, the polymer beginning to precipitate out. After the gas has been introduced for two hours, the precipitate is removed, washed with THF, dried and dialyzed in water in a 10 kD dialysis tube.
- the extracted gel is mixed with 5 times the volume of water and comminuted with a dispersing device into pieces of gel. After 10 minutes of processing, gel pieces with a dimension of between 10 ⁇ m and 100 ⁇ m result. The strength of the gel pieces and their size can be adjusted by selecting the HSA concentration, the glutardialdehyde concentration, the dispersing tool and the processing time. [0048] The gel pieces were autoclaved. In a cell culture experiment, 900 ⁇ L of the comminuted gel was mixed with 100 ⁇ L of a cell suspension which had a concentration of 1 10 4 cells / mL. The resulting cell density was thus 1 '10 3 cells / mL. 500 ⁇ L of this suspension are placed in a 24-well cell culture plate.
- the gel containing cells in the cell culture plate is overlaid with 500 ⁇ L of fresh medium and cultivated at 37 ° C. in an incubator (5% by volume of CO 2 ). The cell number is determined daily. As the culture period progresses, the number of cells in the gel increases (see FIG. 3).
- 500 ⁇ L of this suspension are placed in a 24-well cell culture plate. This corresponds to a gel bed height of approx. 3 mm.
- the gel containing cells in the cell culture plate is overlaid with 500 ⁇ L of fresh medium and cultivated at 37 ° C. in an incubator (5% by volume of CO 2 ).
- the old medium is exchanged for fresh medium every three or four days.
- the concentration of the antibody which was produced by the cells in the course of the cultivation is determined from the supernatant of the old medium.
- the cells are counted on the day of the medium change (see Table 2).
- Figure 1 Cell counts and vitalities / ratio of cell counts to inoculation density
- Figure 2 Culture systems for the sterile continuous cultivation of cells in high densities and for reducing the starting cell density at the beginning of the cultivation in biorectors
- FIG. 3 Increase in the number of cells with the culture duration in the cultivation of CHO cells (CHO - Chinese Hamster Ovary)
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2003245850A AU2003245850A1 (en) | 2002-05-31 | 2003-05-31 | Culture systems for the sterile continuous cultivation of cells |
EP03737924A EP1513920A2 (de) | 2002-05-31 | 2003-05-31 | Kultursysteme zur sterilen kontinuierlichen kultivierung von zellen |
US10/488,818 US20040248290A1 (en) | 2002-05-31 | 2003-05-31 | Culture systems for the sterile continuous cultivation of cells |
DE10393303T DE10393303D2 (de) | 2002-05-31 | 2003-05-31 | Kultursysteme zur sterilen kontinuierlichen Kultivierung von Zellen |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10225179 | 2002-05-31 | ||
DE10225179.7 | 2002-05-31 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003102123A2 true WO2003102123A2 (de) | 2003-12-11 |
WO2003102123A3 WO2003102123A3 (de) | 2004-02-26 |
Family
ID=29432678
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/DE2003/001826 WO2003102123A2 (de) | 2002-05-31 | 2003-05-31 | Kultursysteme zur sterilen kontinuierlichen kultivierung von zellen |
Country Status (5)
Country | Link |
---|---|
US (1) | US20040248290A1 (de) |
EP (1) | EP1513920A2 (de) |
AU (1) | AU2003245850A1 (de) |
DE (2) | DE10393303D2 (de) |
WO (1) | WO2003102123A2 (de) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008101542A1 (en) * | 2007-02-19 | 2008-08-28 | Probiogen Ag | Synthetic polyamino acids, method of their production and use thereof |
US7531351B2 (en) | 2004-06-14 | 2009-05-12 | Probiogen Ag | Liquid-gas-phase exposure reactor for cell culturing |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102007010866A1 (de) * | 2007-03-02 | 2008-09-04 | Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e.V. -Hans-Knöll-Institut- | Vorrichtung und Verfahren zur Durchführung von emersen Mikrokultivierungen bei Mikroorganismen und Zellen |
WO2009052209A2 (en) * | 2007-10-16 | 2009-04-23 | University Of Kansas | Isolation of stem cells and effective control of contamination |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5264359A (en) * | 1988-04-18 | 1993-11-23 | Nitta Gelatin Inc. | Methods for large-scale cultivation of animal cells and for making supporting substrata for the cultivation |
WO2000056861A1 (en) * | 1999-03-22 | 2000-09-28 | Duke University | Methods of microencapsulating pancreatic islet cells |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3821087A (en) * | 1972-05-18 | 1974-06-28 | Dedrick R | Cell culture on semi-permeable tubular membranes |
US3997396A (en) * | 1973-07-02 | 1976-12-14 | Monsanto Company | Method for the in vitro propagation and maintenance of cells |
US4804628A (en) * | 1984-10-09 | 1989-02-14 | Endotronics, Inc. | Hollow fiber cell culture device and method of operation |
JPH0387172A (ja) * | 1989-08-30 | 1991-04-11 | Snow Brand Milk Prod Co Ltd | 細胞封入カプセル体及びその製造法 |
JPH07298876A (ja) * | 1994-03-09 | 1995-11-14 | Res Dev Corp Of Japan | 通液性細胞培養担体と、この担体を用いる培養方法お よび培養装置 |
-
2003
- 2003-05-31 US US10/488,818 patent/US20040248290A1/en not_active Abandoned
- 2003-05-31 DE DE10393303T patent/DE10393303D2/de not_active Expired - Fee Related
- 2003-05-31 AU AU2003245850A patent/AU2003245850A1/en not_active Abandoned
- 2003-05-31 DE DE10325148A patent/DE10325148A1/de not_active Withdrawn
- 2003-05-31 WO PCT/DE2003/001826 patent/WO2003102123A2/de not_active Application Discontinuation
- 2003-05-31 EP EP03737924A patent/EP1513920A2/de not_active Withdrawn
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5264359A (en) * | 1988-04-18 | 1993-11-23 | Nitta Gelatin Inc. | Methods for large-scale cultivation of animal cells and for making supporting substrata for the cultivation |
WO2000056861A1 (en) * | 1999-03-22 | 2000-09-28 | Duke University | Methods of microencapsulating pancreatic islet cells |
Non-Patent Citations (2)
Title |
---|
DATABASE WPI Week 199121 Derwent Publications Ltd., London, GB; AN 1991-152421 XP002264736 & JP 03 087172 A (SNOW BRAND MILK PROD CO LTD), 11. April 1991 (1991-04-11) * |
LEVEE ET AL: "Microencapsulated human bone marrow cultures: a potential culture system for the clonal outgrowth of hematopoietic progenitor cells" BIOTECHNOLOGY AND BIOENGINEERING. INCLUDING: SYMPOSIUM BIOTECHNOLOGY IN ENERGY PRODUCTION AND CONSERVATION, JOHN WILEY & SONS. NEW YORK, US, Bd. 43, Nr. 8, 1994, Seiten 734-739, XP002953979 ISSN: 0006-3592 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7531351B2 (en) | 2004-06-14 | 2009-05-12 | Probiogen Ag | Liquid-gas-phase exposure reactor for cell culturing |
WO2008101542A1 (en) * | 2007-02-19 | 2008-08-28 | Probiogen Ag | Synthetic polyamino acids, method of their production and use thereof |
Also Published As
Publication number | Publication date |
---|---|
AU2003245850A8 (en) | 2003-12-19 |
US20040248290A1 (en) | 2004-12-09 |
WO2003102123A3 (de) | 2004-02-26 |
EP1513920A2 (de) | 2005-03-16 |
DE10325148A1 (de) | 2003-12-11 |
DE10393303D2 (de) | 2005-06-23 |
AU2003245850A1 (en) | 2003-12-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69931800T2 (de) | Strukturierter und poröser silikonkautschuk | |
DE69633629T2 (de) | Produktion von mikrobieller Zellulose mittels eines rotierenden Scheiben-Film-Bioreaktors | |
DE3883505T2 (de) | Biologisch aktive Systeme. | |
DE19537774C2 (de) | Verfahren zur Zellkultivierung und Vorrichtung zur Durchführung des Verfahrens | |
DE2940150A1 (de) | Mikrotraeger-zellkultur | |
JPS626683A (ja) | 複合材料およびその製造方法 | |
DE2715821A1 (de) | Zellkultur-reaktionsgefaess und verfahren zur zellzuechtung | |
DE3409501A1 (de) | Verfahren zur kultivierung von zellen | |
DE69931479T2 (de) | Verfahren zur herstellung von polypeptiden in einem zellfreien system und vorrichtung zu deren ausführung | |
CH654328A5 (de) | Verfahren zur herstellung von durch lebende zellen erzeugten substanzen. | |
DE3888459T2 (de) | Zellzüchtung in kontinuierlicher Dispersionskultur mit einem System zur Gewinnung von Zellprodukten. | |
WO2011051983A1 (en) | In vitro bioengineered animal tissue fiber and its use in the textile industry | |
DE69022778T2 (de) | Zellkultursubstrat, Bioreaktor mit Zellkultursubstrat und therapeutische Vorrichtung vom extrakorporalen Umlauftyp. | |
DE68921974T2 (de) | Bioreaktor. | |
DE3689400T2 (de) | Gefüllter mikroschwamm zur immobilisierung bioaktiver materialien. | |
DE19827552C1 (de) | Verfahren zur Herstellung eines Gels aus Polyvinylalkohol und nach dem Verfahren hergestelltes mechanisch hochstabiles Gel | |
EP1513920A2 (de) | Kultursysteme zur sterilen kontinuierlichen kultivierung von zellen | |
DE4411486C1 (de) | Verfahren und Einrichtung zur Kultivation und Fermentation von Mikroorganismen oder Zellen in flüssigen Medien | |
DE2703834A1 (de) | Verfahren zur herstellung einer unloeslich gemachte enzyme und/oder unloeslich gemachte bakterienzellen enthaltenden zusammensetzung | |
EP1756263B1 (de) | Flüssig-gas-phasenexpositionsreaktor für die zellkultivierung | |
EP0224800B1 (de) | Verfahren und Vorrichtung zum Kultivieren von Zellen | |
EP1297106B1 (de) | Reaktormodul mit kapillarmembranen | |
CH685502A5 (de) | Vorrichtung zur Kultivierung von Mikroorganismen. | |
EP1472336B1 (de) | Verfahren und vorrichtung zur kultivierung von zellen in hohen dichten und zur gewinnung von produkten aus diesen zellen | |
DE3850652T2 (de) | Zellenzuchtverfahren und vorrichtung. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 10488818 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003737924 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2003737924 Country of ref document: EP |
|
REF | Corresponds to |
Ref document number: 10393303 Country of ref document: DE Date of ref document: 20050623 Kind code of ref document: P |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10393303 Country of ref document: DE |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: JP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2003737924 Country of ref document: EP |